AAAAAA

   
Results: 1-18 |
Results: 18
Atrial fibrillation: A risk factor for increased mortality - An AVID registry analysis
Authors: Wyse, DG Love, JC Yao, Q Carlson, MD Cassidy, P Greene, LH Martins, JB Ocampo, C Raitt, MH Schron, E Stamato, NJ Olarte, A
Citation: Dg. Wyse et al., Atrial fibrillation: A risk factor for increased mortality - An AVID registry analysis, J INTERV C, 5(3), 2001, pp. 267-273
Report of the NASPE/NHLBI Round Table on future research directions in atrial fibrillation
Authors: Saskena, S Domanski, MJ Benjamin, EJ Camm, AJ Ezekowitz, MD Gersh, BJ Jalife, J Naccarelli, GV Vlietstra, RE Wyse, DG
Citation: S. Saskena et al., Report of the NASPE/NHLBI Round Table on future research directions in atrial fibrillation, J INTERV C, 5(3), 2001, pp. 345-364
Life-threatening ventricular arrhythmias due to transient or correctable causes: High risk for death in follow-up
Authors: Wyse, DG Friedman, PL Brodsky, MA Beckman, KJ Carlson, MD Curtis, AB Hallstrom, AP Raitt, MH Wilkoff, BL Greene, HL
Citation: Dg. Wyse et al., Life-threatening ventricular arrhythmias due to transient or correctable causes: High risk for death in follow-up, J AM COL C, 38(6), 2001, pp. 1718-1724
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the EuropeanSociety of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation)
Authors: Fuster, V Ryden, LE Asinger, RW Cannom, DS Crijns, HJ Frye, RL Halperin, JL Kay, GN Klein, WW Levy, S McNamara, RL Prystowsky, EN Wann, LS Wyse, DG Gibbons, RJ Antman, EM Alpert, JS Faxon, DP Fuster, V Gregoratos, G Hiratzka, LF Jacobs, AK Russell, RO Smith, SC Klein, WW Alonso-Garcia, A Blomstrom-Lundqvist, C De Backer, G Flather, M Hradec, J Oto, A Parkhomenko, A Silber, S Torbicki, A
Citation: V. Fuster et al., ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the EuropeanSociety of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation), J AM COL C, 38(4), 2001, pp. 1231-1265
Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): Drug testing and as-treated analysis
Authors: Wyse, DG Talajic, M Hafley, GE Buxton, AE Mitchell, LB Kus, TK Packer, DL Kou, WH Lemery, R Santucci, P Grimes, D Hickey, K Stevens, C Singh, SN
Citation: Dg. Wyse et al., Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): Drug testing and as-treated analysis, J AM COL C, 38(2), 2001, pp. 344-351
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation)developed in collaboration with the North American Society of Pacing and Electrophysiology
Authors: Fuster, V Ryden, LE Asinger, RW Cannom, DS Crijns, HJ Frye, RL Halperin, JL Kay, GN Klein, WW Levy, S McNamara, RL Prystowsky, EN Wann, LS Wyse, DG
Citation: V. Fuster et al., ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation)developed in collaboration with the North American Society of Pacing and Electrophysiology, EUR HEART J, 22(20), 2001, pp. 1852-1923
Report of the NASPE/NHLBI round table on future research directions in atrial fibrillation
Authors: Saksena, S Domanski, MJ Benjamin, EJ Camm, AJ Ezekowitz, MD Gersh, BJ Jalife, J Naccarelli, GV Vlietstra, RE Wyse, DG
Citation: S. Saksena et al., Report of the NASPE/NHLBI round table on future research directions in atrial fibrillation, PACE, 24(9), 2001, pp. 1435-1451
Electrical storm presages nonsudden death - The antiarrhythmics versus implantable defibrillators (AVID) trial
Authors: Exner, DV Pinski, SL Wyse, DG Renfroe, EG Follmann, D Gold, M Beckman, KJ Coromilas, J Lancaster, S Hallstrom, AP
Citation: Dv. Exner et al., Electrical storm presages nonsudden death - The antiarrhythmics versus implantable defibrillators (AVID) trial, CIRCULATION, 103(16), 2001, pp. 2066-2071
Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function
Authors: Singh, SN Karasik, P Hafley, GE Pieper, KS Lee, KL Wyse, DG Buxton, AE
Citation: Sn. Singh et al., Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function, AM J CARD, 87(6), 2001, pp. 716-720
Don't you agree, or what part of the problem don't you understand?
Authors: Camm, AJ Levy, S Saksena, S Wyse, DG
Citation: Aj. Camm et al., Don't you agree, or what part of the problem don't you understand?, J INTERV C, 4(4), 2000, pp. 559-560
Conduction time oscillations precede the spontaneous termination of human atrioventricular reciprocating tachycardia
Authors: Exner, DV Mitchell, LB Wyse, DG Sheldon, RS Gillis, AM Cassidy, P Duff, HJ
Citation: Dv. Exner et al., Conduction time oscillations precede the spontaneous termination of human atrioventricular reciprocating tachycardia, J INTERV C, 4(1), 2000, pp. 231-239
The AFFIRM trial: Main trial and substudies - What can we expect?
Authors: Wyse, DG
Citation: Dg. Wyse, The AFFIRM trial: Main trial and substudies - What can we expect?, J INTERV C, 4, 2000, pp. 171-176
Initial energy for electrical cardioversion of atrial fibrillation - Is more better?
Authors: Wyse, DG
Citation: Dg. Wyse, Initial energy for electrical cardioversion of atrial fibrillation - Is more better?, AM J CARD, 86(3), 2000, pp. 324
Cardiac pacemakers and implantable defibrillators in terminal care
Authors: Braun, TC Hagen, NA Hatfield, RE Wyse, DG
Citation: Tc. Braun et al., Cardiac pacemakers and implantable defibrillators in terminal care, J PAIN SYMP, 18(2), 1999, pp. 126-131
Atrial pacing periablation for prevention of paroxysmal atrial fibrillation
Authors: Gillis, AM Wyse, DG Connolly, SJ Dubuc, M Philippon, F Yee, R Lacombe, P Rose, MS Kerr, CD
Citation: Am. Gillis et al., Atrial pacing periablation for prevention of paroxysmal atrial fibrillation, CIRCULATION, 99(19), 1999, pp. 2553-2558
Atrial fibrillation detection and R-wave synchronization by Metrix implantable atrial defibrillator - Implications for long-term efficacy and safety
Authors: Tse, HF Lau, CP Sra, JS Crijns, HJGM Edvardsson, N Kacet, S Wyse, DG
Citation: Hf. Tse et al., Atrial fibrillation detection and R-wave synchronization by Metrix implantable atrial defibrillator - Implications for long-term efficacy and safety, CIRCULATION, 99(11), 1999, pp. 1446-1451
Be still my beating heart - The ablate and pace study
Authors: Wyse, DG
Citation: Dg. Wyse, Be still my beating heart - The ablate and pace study, J INTERV C, 2(2), 1998, pp. 137-138
Atrial fibrillation: Overview of therapeutic trials
Authors: Sharif, MN Wyse, DG
Citation: Mn. Sharif et Dg. Wyse, Atrial fibrillation: Overview of therapeutic trials, CAN J CARD, 14(10), 1998, pp. 1241-1254
Risultati: 1-18 |